AptarGroup acquires Mod3 Pharma's clinical trial manufacturing capabilities
Acquisition Announcement: Aptar Pharma has acquired the clinical trial materials manufacturing capabilities of Mod3 Pharma from SWK Holdings, enhancing its support for early-stage drug development.
Operational Focus: The acquisition allows Aptar to operate an FDA-inspected facility in Boonton, New Jersey, with a focus on orally inhaled nasal drug products for Phase 1 and 2 clinical trials.
Trade with 70% Backtested Accuracy
Analyst Views on SWKH
About SWKH
About the author
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders
Investigation of Companies: Halper Sadeh LLC is investigating SWK Holdings Corporation, 89bio, Inc., Barinthus Biotherapeutics plc, and Verint Systems Inc. for potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to their recent transactions.
Shareholder Rights and Options: The law firm encourages shareholders of the mentioned companies to contact them for information on their legal rights and options, emphasizing that they operate on a contingent fee basis, meaning no upfront legal fees are required.
BRODSKY & SMITH INVESTOR ALERT: Updates on Investigations Involving TrueCar, Inc. (Nasdaq – TRUE), Astria Therapeutics, Inc. (Nasdaq – ATXS), PotlatchDeltic Corporation (Nasdaq – PCH), and SWK Holdings Corporation (Nasdaq – SWKH)
TrueCar Acquisition Investigation: TrueCar, Inc. is set to be acquired by Fair Holdings for $2.55 per share, prompting an investigation into whether the Board breached fiduciary duties by not ensuring a fair process and value for shareholders.
Astria Therapeutics Merger Scrutiny: Astria Therapeutics, Inc. will be acquired by BioCryst Pharmaceuticals for an implied value of $13.00 per share, leading to an investigation regarding the Board's adherence to fiduciary duties in the merger process.
PotlatchDeltic Corporation Deal Review: PotlatchDeltic Corporation is being acquired by Rayonier, with shareholders receiving shares valued at $44.11 each, raising concerns about the Board's fiduciary responsibilities in ensuring fair value during the transaction.
SWK Holdings Corporation Acquisition Inquiry: SWK Holdings Corporation will merge with Runway Growth Finance Corp. in a deal valued at approximately $220 million, with investigations focusing on the Board's duty to conduct a fair process and provide adequate value to shareholders.
